Please assess the completion status of the following clinical trial:

Trial Title: Study on the Safety of Risperidone on Obese or Overweight Patients With Schizophrenia

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients with Schizophrenia or Schizoaffective disorder, in which physicians considered the use of risperidone as treatment under clinical practice with a BMI \>25~* Patients have increased their body weight \>7% in the last year with the previous treatment even with a BMI\< 25~* Patients that have shown intolerance to a previous antipsychotic treatment~Exclusion Criteria:~* Pregnant or lactating patients~* Patients with psychiatry pathology other than Schizophrenia or schizoaffective disorder~* Patients with neurology pathology except Parkinsonism induced by neuroleptics~* Patients with other severe concomitant pathology~* Patients treated with Risperidone in the last 30 days.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- 001 (Type: None): Risperidone As prescribed

Based on this trial design, predict the completion outcome and termination type (if applicable).